A phase 2, open-label study of S-646240 in patients with age-related macular degeneration accompanied by choroidal neovascularization
Latest Information Update: 02 Dec 2014
At a glance
- Drugs S-646240 (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 01 Dec 2014 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan
- 28 May 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jun 2012 New trial record